(Q40923906)

24 September 2017

Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies (English)

1 reference

24 September 2017

0 references

B Wilcken

1

1 reference

24 September 2017

V Wiley

series ordinal

2

1 reference

24 September 2017

G Sherry

series ordinal

3

1 reference

24 September 2017

U Bayliss

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

The Journal of Pediatrics

24 September 2017

1 reference

24 September 2017

127

1 reference

24 September 2017

6

1 reference

24 September 2017

965-970

1 reference

Dried-blood spot screening for cystic fibrosis in the newborn

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Reduced morbidity in patients with cystic fibrosis detected by neonatal screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Neonatal screening for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Gene amplification directly from Guthrie blood spots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Delayed diagnosis of cystic fibrosis in children with a rare genotype (delta F508/R117H).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Population variation of common cystic fibrosis mutations. The Cystic Fibrosis Genetic Analysis Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Diagnosis of cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

A Novel Mutation in the Cystic Fibrosis Gene in Patients with Pulmonary Disease but Normal Sweat Chloride Concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Abnormal frequency of delta F508 mutation in neonatal transitory hypertrypsinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

Neonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970040-4

10.1016/S0022-3476(95)70040-4

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference